Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Strittmatter

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Pathology|June 25, 2016
Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal NeovascularizationKarin Strittmatter, Hayley Pomeroy, Alexander G Marneros
Carcinogenesis|June 10, 2010
A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesisAdrian Zumsteg, Karin Strittmatter, Daniela Klewe-Nebenius, et al.
Journal of Leukocyte Biology|June 24, 2006
Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic miceBirgit Schaffhauser, Tanja Veikkola, Karin Strittmatter, et al.
Elife|December 11, 2020
Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularizationJakob Malsy, Andrea C Alvarado, Joseph O Lamontagne, et al.
Cancer Research|December 3, 2004
Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesisIvana Crnic, Karin Strittmatter, Ugo Cavallaro, et al.
Cancer Research|November 17, 2007
Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesisTibor Schomber, Lucie Kopfstein, Valentin Djonov, et al.
Molecular Cancer Research : MCR|May 8, 2012
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinomaAdrian Zumsteg, Christoph Caviezel, Laura Pisarsky, et al.
Molecular Cancer Therapeutics|January 14, 2009
Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesisTibor Schomber, Adrian Zumsteg, Karin Strittmatter, et al.
The EMBO Journal|June 2, 2007
Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin functionAngelika Kren, Vanessa Baeriswyl, François Lehembre, et al.
International Journal of Cancer|September 13, 2013
Loss of stromal JUNB does not affect tumor growth and angiogenesisJennifer Braun, Karin Strittmatter, Tobias Nübel, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|June 25, 2016
Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal NeovascularizationKarin Strittmatter, Hayley Pomeroy, Alexander G Marneros
Carcinogenesis|June 10, 2010
A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesisAdrian Zumsteg, Karin Strittmatter, Daniela Klewe-Nebenius, et al.
Journal of Leukocyte Biology|June 24, 2006
Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic miceBirgit Schaffhauser, Tanja Veikkola, Karin Strittmatter, et al.
Elife|December 11, 2020
Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularizationJakob Malsy, Andrea C Alvarado, Joseph O Lamontagne, et al.
Cancer Research|December 3, 2004
Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesisIvana Crnic, Karin Strittmatter, Ugo Cavallaro, et al.
Cancer Research|November 17, 2007
Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesisTibor Schomber, Lucie Kopfstein, Valentin Djonov, et al.
Molecular Cancer Research : MCR|May 8, 2012
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinomaAdrian Zumsteg, Christoph Caviezel, Laura Pisarsky, et al.
Molecular Cancer Therapeutics|January 14, 2009
Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesisTibor Schomber, Adrian Zumsteg, Karin Strittmatter, et al.
The EMBO Journal|June 2, 2007
Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin functionAngelika Kren, Vanessa Baeriswyl, François Lehembre, et al.
International Journal of Cancer|September 13, 2013
Loss of stromal JUNB does not affect tumor growth and angiogenesisJennifer Braun, Karin Strittmatter, Tobias Nübel, et al.
Pageof 3